This revised document provides useful information about the prevention, diagnosis, and management of HBV infection.
Target Population: Physicians and other healthcare providers who diagnose and manage hepatitis B virus (HBV) infection
Sponsoring Organization: American Association for the Study of Liver Diseases; endorsed by the Infectious Diseases Society of AmericaType: Evidence-based guidelines using a categorical rating system
Key Points: This document updates guidelines that were last revised in 2007.
Screening for HBV infection is recommended for individuals born in high- or intermediate-prevalence regions (e.g., Asia, Africa, many countries in South America) and in U.S.-born persons at increased risk, including those starting cancer chemotherapy or immunosuppressive therapy. Such individuals should be tested for hepatitis B surface antigen (HBsAg) and…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)